+20.1%
GSK vs PNR
-47.6%
+67.7%
-19.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | PNR | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | -0.3% | +0.3% | +0.1% |
| 7D | -3.5% | -6.0% | +2.5% | -2.5% |
| 30D | -3.4% | -14.0% | +10.5% | -1.0% |
| 3M | -8.1% | -21.7% | +13.6% | -5.1% |
| 6M | -11.1% | -37.3% | +26.1% | -5.2% |
| YTD | +0.7% | -45.1% | +45.9% | +8.6% |
| 1Y | +20.1% | -49.1% | +69.3% | +29.7% |
| All | +20.1% | -47.6% | +67.7% | +29.7% |
Cumulative growth
Daily Returns
Daily percentage return beside PNR.
Daily Out/Under-Performance
Portfolio return minus PNR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PNR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded PNR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling